BDRX

Conviction 4HealthcareScan · Mon, Aug 10, 2026

Three inside up

BDRX$1.61+4.55%

ResistanceSupportVol 14

Vol MA14 369.07K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Biodexa Pharmaceuticals PlcPharmaceutical Preparationswww.biodexapharma.com ↗

Price1.61

Change+4.55%

Gap+3.25%

Rel volume0.00×

Avg volume267.98K

Avg $ vol445.93K

SMA 201.70

SMA 502.47

SMA 2002.95

Price vs 50-34.71%

Price vs 200-45.47%

MA stackbearish

50/200 cross—

Supertrenddown · 2.02

RSI (14)38

MACD hist0.04

MACD crossbull · 3d

Stoch %K / %D69 / 52

ADX (14)42

+DI / −DI11 / 24

RSI divergence—

MACD divergenceBullish

ATR %+14.36%

ADR %13.21%

52w high10.90

52w low0.6116

From 52w high-85.23%

Above 52w low+163.24%

New 52w highNo

SqueezeOff

Bollinger width69.27%

%B0.42

Donchian pos45.04%

Donchian high2.33

Donchian low1.02

AVWAP (52w high)3.03

vs AVWAP high-46.95%

AVWAP (52w low)1.53

vs AVWAP low+4.92%

OBV trendDown

Chaikin MF (20)-0.22

Today vs 20d0.00×

Avg vol (14d)369.07K

Avg vol (20d)267.98K

Avg $ vol (20d)445.93K

Market cap363.57B

RS 3m (vs SPY)-74.01%

RS 6m (vs SPY)+4.35%

RS line new highNo

Trend template1/8

Technical rank31.6

1 week+13.38%

1 month-35.34%

3 months-62.12%

6 months+29.84%

1 year-76.32%

YTD-34.55%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value363.57B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out746.11K

Employees11

ListedMon, Dec 7, 2015

Free float561.96K

Float %62.2%

Short interest9.93K

Days to cover0.5d

Short volume86.1%

Squeeze score26 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank31.6 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree inside up

News sentiment—

Congress activity

Disclosed STOCK Act trades in BDRX

All disclosures →

No recent disclosed trades by Congress in BDRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BDRX

No recent insider (Form 4) filings in BDRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BDRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.